Your browser doesn't support javascript.
loading
Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV/AIDS patients receiving antiretroviral therapy: a retrospective cohort study.
Jiang, Junjun; Qin, Fengxiang; Meng, Sirun; Nehl, Eric J; Huang, Jinping; Liu, Yanfen; Zou, Jun; Dong, Wenyi; Huang, Jiegang; Chen, Hui; Zang, Ning; Liang, Bingyu; Ning, Chuanyi; Liao, Yanyan; Luo, Chaolian; Liu, Huifang; Liu, Xin; Wang, Jian; Zhou, Oulu; Le, Thuy; Ye, Li; Wu, Fengyao; Liang, Hao.
Affiliation
  • Jiang J; Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, School of Public Health, Guangxi Medical University, Nanning, People's Republic of China.
  • Qin F; Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, School of Public Health, Guangxi Medical University, Nanning, People's Republic of China.
  • Meng S; Fourth People's Hospital of Nanning, Nanning, People's Republic of China.
  • Nehl EJ; Rollins School of Public Health, Emory University, Atlanta, GA, USA.
  • Huang J; Fourth People's Hospital of Nanning, Nanning, People's Republic of China.
  • Liu Y; Fourth People's Hospital of Nanning, Nanning, People's Republic of China.
  • Zou J; Fourth People's Hospital of Nanning, Nanning, People's Republic of China.
  • Dong W; Fourth People's Hospital of Nanning, Nanning, People's Republic of China.
  • Huang J; Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, School of Public Health, Guangxi Medical University, Nanning, People's Republic of China.
  • Chen H; Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, School of Public Health, Guangxi Medical University, Nanning, People's Republic of China.
  • Zang N; Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, People's Republic of China.
  • Liang B; Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, School of Public Health, Guangxi Medical University, Nanning, People's Republic of China.
  • Ning C; Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, People's Republic of China.
  • Liao Y; Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, People's Republic of China.
  • Luo C; Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, People's Republic of China.
  • Liu H; Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, People's Republic of China.
  • Liu X; Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, People's Republic of China.
  • Wang J; Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, School of Public Health, Guangxi Medical University, Nanning, People's Republic of China.
  • Zhou O; Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, School of Public Health, Guangxi Medical University, Nanning, People's Republic of China.
  • Le T; Division of Infectious Diseases, Duke University School of Medicine, Durham, NC, USA.
  • Ye L; Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
  • Wu F; Guangxi Key Laboratory of AIDS Prevention and Treatment & Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, School of Public Health, Guangxi Medical University, Nanning, People's Republic of China.
  • Liang H; Guangxi Collaborative Innovation Center for Biomedicine, Life Sciences Institute, Guangxi Medical University, Nanning, People's Republic of China.
Emerg Microbes Infect ; 8(1): 367-376, 2019.
Article in En | MEDLINE | ID: mdl-31851879
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Trimethoprim, Sulfamethoxazole Drug Combination / Acquired Immunodeficiency Syndrome / AIDS-Related Opportunistic Infections / Talaromyces / Mycoses Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Emerg Microbes Infect Year: 2019 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Trimethoprim, Sulfamethoxazole Drug Combination / Acquired Immunodeficiency Syndrome / AIDS-Related Opportunistic Infections / Talaromyces / Mycoses Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Emerg Microbes Infect Year: 2019 Document type: Article